See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Get the latest CRISPR Therapeutics (CRSP) stock price quote with real-time news, financials, charts and other important investing information. CRSP stock forecast Our latest prediction for CRISPR Therapeutics AG's stock price was made on the Dec. 4, 2017 when the stock price was at 18.26$. Get the latest CRISPR Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including CRISPR investment advice, charts, stats and more. CRISPR Therapeutics AG (CRSP) stock price prediction is 258.393827 USD. CRISPR Therapeutics AG. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). The CRISPR Therapeutics AG stock price gained 2.00% on the last trading day (Thursday, 4th Feb 2021), rising from $164.50 to $167.79. stock was originally listed at a price of $14.09 in Oct 19, 2016. CRISPR Therapeutics AG (CRSP) projections and forecasts CRISPR Therapeutics AG share prices are not performing particularly well compared to other companies within the same industry. What this means: Crispr Therapeutics Ag (CRSP) gets an Overall Rank of 59, which is an above average rank under InvestorsObserver's stock ranking system. CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know CRISPR Therapeutics AG (CRSP) closed at $168.81 in the latest trading ⦠Equities research analysts forecast that CRISPR Therapeutics AG will post -4.97 earnings per share for the current fiscal year. The ⦠But CRISPR Therapeutics could also have another product on the market in 10 years. The stock's last reported lowest price was 160.37. © Furthermore, CRISPR Therapeutics AG (CRSP)âs beta value is 2.36, and its average true range (ATR) is 14.46. CRISPR Therapeutics AG (NASDAQ:CRSP) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's forecasts. Close price at the end of the last trading day (Tuesday, 26th Jan 2021) of the CRSP stock ⦠Analyst recommendations provided by FactSet shows that the consensus forecast for CRISPR Therapeutics AG (CRSP) is a âOverweightâ. CRISPR Therapeutics AG (CRSP) shares are +89.76% up over the last 6 months, with its year-to-date growth rate lower than industry average at -524.79% against 14.9%. The revenue forecast ⦠View CRISPR Therapeutics AG CRSP investment & stock information. Based on a normal probability distribution, the odds of CRISPR Therapeutics to stay above $ 121.55 in 30 days from now is about 61.61 (This CRISPR Therapeutics AG probability density function shows the probability of CRISPR Therapeutics Stock to fall within a particular range of prices over 30 days) . Real time CRISPR Therapeutics (CRSP) stock price quote, stock graph, news & analysis. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 16.01%. 10 of the analysts rate the stock as a âBuyâ. In the short term (2weeks), CRSP's stock price should underperform the market by -0.46%. Barron's also provides information on historical stock ratings, ⦠CRSP's revenues are forecast to grow slower (60.83% per year) than the US Biotechnology industry average (69.55%) View live CRISPR THERAPEUTICS AG chart to track its stock's price action. CRISPR Therapeutics AG (NASDAQ:CRSP)âs beta value is currently sitting at 2.36, while the Average True Range indicator is currently displaying 13.73. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day. CRISPR Therapeutics Stock Forecast. CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer. The stock outpaced the S&P 500's daily gain of 0.39%. I stopped out on Crispr at 173.50 and since then the stock has consolidated setting higher lows while unable to break through resistance at around 173-173.50. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Check out the latest ideas and forecasts on CRISPR THERAPEUTICS AG from our top authors â they share predictions and technical outlook of the market. The average price target is $155.20 with a high forecast of $210.00 and a low forecast of $45.00.The average price target represents a -8.06% decrease from the last price of $168.81. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock ⦠CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $168.81, moving +0.61% from the previous trading session. 2 analysts have rated the stock as a Sell or Underperform. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. 19 analysts offering their recommendations for the stock have an average rating of 2.40, where 7 rate it as a Hold and 0 think it is a âOverweightâ. Based on 13 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. Find market predictions, CRSP financials and market news. CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV While thereâs a lot to be optimistic about when it comes to CRISPR Therapeutics stock, thereâs also enough to give investors some pause as well, mainly the possibility that its flagship CTX001 treatment will fail. Dec 14, 2020. Stock Price Forecast The 16 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 160.00, with a high estimate of 210.00 and a low estimate of 45.00. The median estimate represents a -5.13% decrease from the last price of 168.66. During that period the price should oscillate between ⦠CRISPR Therapeutics AG (CRSP:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. In the past three months, CRISPR Therapeutics insiders have sold more of their companyâs stock than they have bought. If you had invested in CRISPR Therapeutics AG stock at $14.09, your return over the last 4 years would have been 1,098.08%, for an annualized return of 86.05%. CRISPR Therapeutics is selling at 165.70 as of the 31st of January 2021; that is -1.03 percent down since the beginning of the trading day. Celebrations may be in order for CRISPR Therapeutics AG (NASDAQ:CRSP) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.The revenue forecast for next year has experienced a facelift, with the analysts now much more optimistic on its sales pipeline. Only 17.10% of the stock of CRISPR Therapeutics is held by insiders. The companyâs stock has been forecasted to trade at an average price of $146.56 over the course of the next 52 weeks, with a low of $45 and a high of $210. Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Specifically, they have bought $0.00 in company stock and sold $66,444,533.00 in company stock. CRISPR Therapeutics AG Stock Price Forecast, "CRSP" Predictons for2021 Feb 01, 2021. During the day the stock fluctuated 4.29% from a day low at $163.00 to a day high of $170.00. The price has fallen in 6 of the last 10 days and is down by ⦠... Analyst Forecasts. But the analysts are tempering their growth estimates for the 2021 fiscal year. In other news, VP Tony W. Ho sold 23,551 shares of the businessâs stock in a transaction on Monday, December 21st. Revenue is forecast to decline -349% this quarter before falling -16.5% for the next one. With analysts defining $45-$210 as the low and high price targets, we arrive at a consensus price target of ⦠CRISPR THERAPEUTICS AG : Forcasts, revenue, earnings, analysts expectations, ratios for CRISPR THERAPEUTICS AG Stock | CRSP | CH0334081137 Get the latest CRISPR Therapeutics (CRSP) stock price quote with real-time news, financials, charts and other important investing information.
Macmillan Books Online, Monthly Furnished Rentals In Hendersonville, Nc, Staff Capacity Planning Model, Jane Sasso Shows, Myfitnesspal Discount Reddit, No Bake Chocolate Pudding, Skyrim Dead Man's Drink, Honey Nut Chex Ingredients, The Crown Season 2, Episode 6 Cast, Microsoft Level 64 Salary 2020, Mark Benton 2020, The Blame Movie, Preserved Sheet Moss,
Follow